This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Janssen Vaccines & Prevention B.v.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Bunga Berdien Siregar: Innovator in Tau Protein Research
Introduction
Bunga Berdien Siregar is a notable inventor based in Amstelveen, Netherlands. He has made significant contributions to the field of biomedical research, particularly in the study of tau proteins, which are associated with neurodegenerative diseases.
Latest Patents
Bunga holds a patent for "Binding molecules that specifically bind to tau." This invention relates to binding molecules and antigen-binding fragments that specifically target microtubule-associated protein tau. The patent also encompasses diagnostic, prophylactic, and therapeutic methods utilizing these binding molecules or antigen-binding fragments. He has 1 patent to his name.
Career Highlights
Bunga is currently employed at Janssen Vaccines & Prevention B.V., where he continues to advance his research in the field. His work focuses on developing innovative solutions for health challenges related to tau proteins.
Collaborations
Bunga collaborates with talented colleagues, including Roosmarijn Janson and Constantin Adrian Apetri, who contribute to his research endeavors.
Conclusion
Bunga Berdien Siregar is a pioneering inventor whose work on tau-binding molecules holds promise for future diagnostic and therapeutic applications. His contributions to the field are invaluable and reflect his commitment to advancing medical science.